Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jun;20(6):590-1.
doi: 10.1038/nm.3595.

Overcoming Drug Development Bottlenecks With Repurposing: Old drugs learn new tricks

Affiliations

Overcoming Drug Development Bottlenecks With Repurposing: Old drugs learn new tricks

Stephen M Strittmatter. Nat Med. 2014 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

COMPETING FINANCIAL INTERESTS

The author declares no competing financial interests.

Figures

Figure 1
Figure 1
Repurposing of drugs for rapid development. Existing compounds typically have identified molecular targets and primary indications in which they have either reached approval status or been sidelined somewhere along the pipeline, for efficacy or business reasons. If compounds are made available for further research, then investigation may identify new indications for the same target or new molecular targets with separate indications. A parallel pathway to approval for a repurposed indication can be achieved more robustly by relying on prior safety and tolerability experience with the original indication.

References

    1. Scannell JW, Blanckley A, Boldon H, Warrington B. Nat Rev Drug Discov. 2012;11:191–200. - PubMed
    1. DiMasi JA, Feldman L, Seckler A, Wilson A. Clin Pharmacol Ther. 2010;87:272–277. - PubMed
    1. Arrowsmith J, Miller P. Nat Rev Drug Discov. 2013;12:569. - PubMed
    1. Nygaard HB, van Dyck CH, Strittmatter SM. Alzheimers Res Ther. 2014;6:8. - PMC - PubMed
    1. Rothstein JD, et al. Nature. 2005;433:73–77. - PubMed

MeSH terms